GlassScriptPhysician profile
Matthew Robert Paszek
NPI 1346403870
$4,751.26
in general payments reported to CMS, 2019-2025
33 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $834 · 2020: $317 · 2021: $1,326 · 2022: $699 · 2023: $515 · 2024: $347 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,707.91 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $967.50 | 2019-2023 | Xtandi |
| Abbvie INC. | $193.65 | 2019-2025 | |
| Procept Biorobotics Corporation | $187.96 | 2025 | |
| Coloplast Corp | $149.81 | 2019-2024 | Speedicath, Altis |
| Bayer Healthcare Pharmaceuticals INC. | $138.26 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $134.51 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $133.80 | 2019-2025 | Moses 550 Dfl, General - Male Sui, Spaceoar Vue System - 10ml |
| Urovant Sciences INC | $101.42 | 2021-2022 | |
| Teleflex LLC | $92.12 | 2021-2023 | Urolift |
| Pfizer INC. | $80.14 | 2019-2022 | |
| Travere Therapeutics, INC. | $79.63 | 2019-2021 | |
| Janssen Biotech, INC. | $68.14 | 2019-2022 | |
| Allergan, INC. | $66.67 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $66.45 | 2019-2023 | Xiaflex |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $59.26 | 2023 | |
| Myovant Sciences INC. | $58.58 | 2021 | |
| Antares Pharma, INC. | $53.67 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $50.99 | 2019-2020 | |
| Genzyme Corporation | $50.92 | 2022 | |
| Baxter Healthcare | $43.06 | 2021-2022 | |
| Blue Earth Diagnostics | $40.87 | 2021-2022 | |
| Medtronic, INC. | $34.52 | 2022 | |
| Ethicon US, LLC | $29.30 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.45 | 2020 | |
| Convatec INC. | $21.54 | 2022 | |
| Olympus America INC. | $21.04 | 2022 | |
| Aytu Biopharma, INC. | $19.91 | 2019 | |
| Axonics, INC. | $17.82 | 2021 | |
| Tolmar, INC. | $16.78 | 2023 | |
| Metuchen Pharmaceuticals | $15.33 | 2019 | |
| Urogen Pharma, INC. | $13.63 | 2022 | |
| Photocure INC | $12.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Paszek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.